Section He-P 4035.25 - Release of Individuals Containing Unsealed Byproduct Material or Implants Containing Byproduct Material(a) A licensee shall authorize the release from its control any individual who has been administered unsealed byproduct material or implants containing byproduct material if: (1) The total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed 5 millisieverts (0.5 rem); or(2) The calculated doses, based on methods and tables of activities described in NUREG-1556 (Vol. 9), "Consolidated Guidance about Materials Licenses: Program-Specific Guidance About Medical Use Licenses" show that the total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed 5 millisieverts (0.5 rem).(b) A licensee shall provide the released individual, or the individual's parent or guardian, with instructions, including written instructions, on actions recommended to maintain doses to other individuals as low as is reasonably achievable if the total effective dose equivalent to any other individual is likely to exceed 1 millisievert (0.1 rem).(c) If the total effective dose equivalent to a nursing infant or child could exceed 1 millisievert (0.1 rem), assuming there are no interruption of breast-feeding, the instructions shall also include:(1) Guidance on the interruption or discontinuation of breast-feeding; and(2) Information on the potential consequences, if any, of failure to follow the guidance.(d) A licensee shall maintain a record of the basis for authorizing the release of an individual in accordance with He-P 4035.25(f)(1).(e) The licensee shall maintain a record of instructions provided to a breast-feeding female in accordance with He-P 4035.25(f)(2).(f) Records of the released individuals containing unsealed byproduct material or implants containing byproduct material:(1) A licensee shall retain a record of the basis for authorizing the release of an individual in accordance with He-P 4035.25, if the total effective dose equivalent is calculated by: a. Using the retained activity rather than the activity administered;b. Using an occupancy factor less than 0.25 at 1 meter;c. Using the biological or effective half-life; ord. Considering the shielding by tissue;(2) A licensee shall retain a record that the instructions required by He-P 4035.25(b) and (c) were provided to a breast-feeding female if the radiation dose to the infant or child from continued breast-feeding could result in a total effective dose equivalent exceeding 5 millisieverts (0.5 rem); and(3) The records required by He-P 4035.25(f)(1) and (f) (2) above shall be retained for 3 years after the date of release of the individual.N.H. Admin. Code § He-P 4035.25
(See Revision Note at part heading for He-P 4035) #6942, eff 2-1-99; ss by #8800, INTERIM, eff 2-1-07, EXPIRED: 7-31-07
New. #8959, eff 8-7-07
Amended by Volume XXXV, Number 32 Filed August 13, 2015, Proposed by #10897, Effective 7/22/2015, Expires1/18/2016.Amended by Volume XXXVI Number 01, Filed January 7, 2016, Proposed by #11011, Effective 1/15/2016, Expires 1/15/2026.Amended by Volume XL Number 24, Filed June 11, 2020, Proposed by #13048, Effective 6/2/2020, Expires 6/2/2030.Amended by Volume XLII Number 45, Filed November 10, 2022, Proposed by #13473, Effective 10/25/2022, Expires 10/25/2032